Global Digital Therapeutics for Smoking Cessation Market 2026 by Company, Regions, Type and Application, Forecast to 2032

September 2026 | 116 pages | ID: G9EDA7CC1A01EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Digital Therapeutics for Smoking Cessation market size was valued at US$ 722 million in 2025 and is forecast to a readjusted size of US$ 2831 million by 2032 with a CAGR of 21.5% during review period.

Digital smoking cessation therapies refer to digital healthcare products that utilize software programs, mobile applications (Apps), artificial intelligence algorithms, wearable devices, sensors, virtual reality (VR), and telemedicine to provide smokers with clinically evidence-based smoking cessation intervention programs. These therapies employ cognitive behavioral therapy (CBT), motivational enhancement therapy (MET), mindfulness training, behavioral feedback, nicotine dependence management, relapse risk prediction, and personalized health guidance to help users reduce tobacco dependence, improve smoking cessation adherence, and increase long-term smoking cessation success rates. Unlike ordinary smoking cessation apps, strictly speaking digital smoking cessation therapies typically require clinical validation and are used as medical intervention tools for disease treatment or health management. They can be used independently or in combination with medication, nicotine replacement therapy (NRT), and under physician guidance.

Digital smoking cessation therapies are demonstrating immense potential to transform the global tobacco control landscape due to their superior accessibility and cost advantages. Evidence-based medicine has clearly confirmed their effectiveness: a network meta-analysis encompassing 152 trials showed that personalized and group-tailored digital interventions can increase smoking cessation rates by 86% to 93% compared to conventional care, with SMS-based interventions being particularly effective, increasing the success rate by 63%. More advanced immediate adaptive interventions and virtual reality digital therapies integrating cognitive behavioral therapy can provide precise support at users' most vulnerable moments through real-time monitoring and personalized feedback—something virtually impossible in traditional human services. Despite challenges such as varying levels of engagement and data security, with the deep integration of artificial intelligence technology and the continuous accumulation of clinical validation, these digital therapies, combining low cost, high coverage, and personalization, are expected to become a key supplement to traditional smoking cessation services, propelling tobacco control efforts into a new era of more precise and inclusive digital care.

Report Scope

This report is a detailed and comprehensive analysis for global Digital Therapeutics for Smoking Cessation market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Digital Therapeutics for Smoking Cessation market size and forecasts, in consumption value ($ Million), 2021-2032

Global Digital Therapeutics for Smoking Cessation market size and forecasts by region and country, in consumption value ($ Million), 2021-2032

Global Digital Therapeutics for Smoking Cessation market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032

Global Digital Therapeutics for Smoking Cessation market shares of main players, in revenue ($ Million), 2021-2026

The Primary Objectives in This Report Are:

  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for Digital Therapeutics for Smoking Cessation
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace
This report profiles key players in the global Digital Therapeutics for Smoking Cessation market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Click Therapeutics, CureApp, Pelago(Quit Genius), Ditch Labs, MindCotine, Kwit, Pivot Health, Carrot Inc., Beijing Wenzhi Technology Co., Ltd., Hangzhou Yisu Technology Co., Ltd., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Digital Therapeutics for Smoking Cessation market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Market segment by Type

  • Cognitive Behavioral Therapy (CBT)-based
  • AI-driven Personalized Intervention
  • Digital Behavioral Feedback
  • Virtual Reality (VR)-assisted

Market segment by Business Models

  • B2C
  • B2B
  • B2B2C

Market segment by Application

  • Digital Smoking Cessation Therapy for Adults
  • Digital Smoking Cessation Therapy for Adolescents
  • Digital Smoking Cessation Therapy for Special Populations

Market segment by players, this report covers

  • Click Therapeutics
  • CureApp
  • Pelago(Quit Genius)
  • Ditch Labs
  • MindCotine
  • Kwit
  • Pivot Health
  • Carrot Inc.
  • Beijing Wenzhi Technology Co., Ltd.
  • Hangzhou Yisu Technology Co., Ltd.
  • Shanghai Akcare Medical Technology Co., Ltd.

Market segment by regions, regional analysis covers

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
  • South America (Brazil, Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Chapter Outline

Chapter 1, to describe Digital Therapeutics for Smoking Cessation product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Digital Therapeutics for Smoking Cessation, with revenue, gross margin, and global market share of Digital Therapeutics for Smoking Cessation from 2021 to 2026.

Chapter 3, the Digital Therapeutics for Smoking Cessation competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Digital Therapeutics for Smoking Cessation market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Digital Therapeutics for Smoking Cessation.

Chapter 13, to describe Digital Therapeutics for Smoking Cessation research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Digital Therapeutics for Smoking Cessation by Type
  1.3.1 Overview: Global Digital Therapeutics for Smoking Cessation Market Size by Type: 2021 Versus 2025 Versus 2032
  1.3.2 Global Digital Therapeutics for Smoking Cessation Consumption Value Market Share by Type in 2025
  1.3.3 Cognitive Behavioral Therapy (CBT)-based
  1.3.4 AI-driven Personalized Intervention
  1.3.5 Digital Behavioral Feedback
  1.3.6 Virtual Reality (VR)-assisted
1.4 Classification of Digital Therapeutics for Smoking Cessation by Business Models
  1.4.1 Overview: Global Digital Therapeutics for Smoking Cessation Market Size by Business Models: 2021 Versus 2025 Versus 2032
  1.4.2 Global Digital Therapeutics for Smoking Cessation Consumption Value Market Share by Business Models in 2025
  1.4.3 B2C
  1.4.4 B2B
  1.4.5 B2B2C
1.5 Global Digital Therapeutics for Smoking Cessation Market by Application
  1.5.1 Overview: Global Digital Therapeutics for Smoking Cessation Market Size by Application: 2021 Versus 2025 Versus 2032
  1.5.2 Digital Smoking Cessation Therapy for Adults
  1.5.3 Digital Smoking Cessation Therapy for Adolescents
  1.5.4 Digital Smoking Cessation Therapy for Special Populations
1.6 Global Digital Therapeutics for Smoking Cessation Market Size & Forecast
1.7 Global Digital Therapeutics for Smoking Cessation Market Size and Forecast by Region
  1.7.1 Global Digital Therapeutics for Smoking Cessation Market Size by Region: 2021 VS 2025 VS 2032
  1.7.2 Global Digital Therapeutics for Smoking Cessation Market Size by Region, (2021-2032)
  1.7.3 North America Digital Therapeutics for Smoking Cessation Market Size and Prospect (2021-2032)
  1.7.4 Europe Digital Therapeutics for Smoking Cessation Market Size and Prospect (2021-2032)
  1.7.5 Asia-Pacific Digital Therapeutics for Smoking Cessation Market Size and Prospect (2021-2032)
  1.7.6 South America Digital Therapeutics for Smoking Cessation Market Size and Prospect (2021-2032)
  1.7.7 Middle East & Africa Digital Therapeutics for Smoking Cessation Market Size and Prospect (2021-2032)

2 COMPANY PROFILES

2.1 Click Therapeutics
  2.1.1 Click Therapeutics Details
  2.1.2 Click Therapeutics Major Business
  2.1.3 Click Therapeutics Digital Therapeutics for Smoking Cessation Product and Solutions
  2.1.4 Click Therapeutics Digital Therapeutics for Smoking Cessation Revenue, Gross Margin and Market Share (2021-2026)
  2.1.5 Click Therapeutics Recent Developments and Future Plans
2.2 CureApp
  2.2.1 CureApp Details
  2.2.2 CureApp Major Business
  2.2.3 CureApp Digital Therapeutics for Smoking Cessation Product and Solutions
  2.2.4 CureApp Digital Therapeutics for Smoking Cessation Revenue, Gross Margin and Market Share (2021-2026)
  2.2.5 CureApp Recent Developments and Future Plans
2.3 Pelago(Quit Genius)
  2.3.1 Pelago(Quit Genius) Details
  2.3.2 Pelago(Quit Genius) Major Business
  2.3.3 Pelago(Quit Genius) Digital Therapeutics for Smoking Cessation Product and Solutions
  2.3.4 Pelago(Quit Genius) Digital Therapeutics for Smoking Cessation Revenue, Gross Margin and Market Share (2021-2026)
  2.3.5 Pelago(Quit Genius) Recent Developments and Future Plans
2.4 Ditch Labs
  2.4.1 Ditch Labs Details
  2.4.2 Ditch Labs Major Business
  2.4.3 Ditch Labs Digital Therapeutics for Smoking Cessation Product and Solutions
  2.4.4 Ditch Labs Digital Therapeutics for Smoking Cessation Revenue, Gross Margin and Market Share (2021-2026)
  2.4.5 Ditch Labs Recent Developments and Future Plans
2.5 MindCotine
  2.5.1 MindCotine Details
  2.5.2 MindCotine Major Business
  2.5.3 MindCotine Digital Therapeutics for Smoking Cessation Product and Solutions
  2.5.4 MindCotine Digital Therapeutics for Smoking Cessation Revenue, Gross Margin and Market Share (2021-2026)
  2.5.5 MindCotine Recent Developments and Future Plans
2.6 Kwit
  2.6.1 Kwit Details
  2.6.2 Kwit Major Business
  2.6.3 Kwit Digital Therapeutics for Smoking Cessation Product and Solutions
  2.6.4 Kwit Digital Therapeutics for Smoking Cessation Revenue, Gross Margin and Market Share (2021-2026)
  2.6.5 Kwit Recent Developments and Future Plans
2.7 Pivot Health
  2.7.1 Pivot Health Details
  2.7.2 Pivot Health Major Business
  2.7.3 Pivot Health Digital Therapeutics for Smoking Cessation Product and Solutions
  2.7.4 Pivot Health Digital Therapeutics for Smoking Cessation Revenue, Gross Margin and Market Share (2021-2026)
  2.7.5 Pivot Health Recent Developments and Future Plans
2.8 Carrot Inc.
  2.8.1 Carrot Inc. Details
  2.8.2 Carrot Inc. Major Business
  2.8.3 Carrot Inc. Digital Therapeutics for Smoking Cessation Product and Solutions
  2.8.4 Carrot Inc. Digital Therapeutics for Smoking Cessation Revenue, Gross Margin and Market Share (2021-2026)
  2.8.5 Carrot Inc. Recent Developments and Future Plans
2.9 Beijing Wenzhi Technology Co., Ltd.
  2.9.1 Beijing Wenzhi Technology Co., Ltd. Details
  2.9.2 Beijing Wenzhi Technology Co., Ltd. Major Business
  2.9.3 Beijing Wenzhi Technology Co., Ltd. Digital Therapeutics for Smoking Cessation Product and Solutions
  2.9.4 Beijing Wenzhi Technology Co., Ltd. Digital Therapeutics for Smoking Cessation Revenue, Gross Margin and Market Share (2021-2026)
  2.9.5 Beijing Wenzhi Technology Co., Ltd. Recent Developments and Future Plans
2.10 Hangzhou Yisu Technology Co., Ltd.
  2.10.1 Hangzhou Yisu Technology Co., Ltd. Details
  2.10.2 Hangzhou Yisu Technology Co., Ltd. Major Business
  2.10.3 Hangzhou Yisu Technology Co., Ltd. Digital Therapeutics for Smoking Cessation Product and Solutions
  2.10.4 Hangzhou Yisu Technology Co., Ltd. Digital Therapeutics for Smoking Cessation Revenue, Gross Margin and Market Share (2021-2026)
  2.10.5 Hangzhou Yisu Technology Co., Ltd. Recent Developments and Future Plans
2.11 Shanghai Akcare Medical Technology Co., Ltd.
  2.11.1 Shanghai Akcare Medical Technology Co., Ltd. Details
  2.11.2 Shanghai Akcare Medical Technology Co., Ltd. Major Business
  2.11.3 Shanghai Akcare Medical Technology Co., Ltd. Digital Therapeutics for Smoking Cessation Product and Solutions
  2.11.4 Shanghai Akcare Medical Technology Co., Ltd. Digital Therapeutics for Smoking Cessation Revenue, Gross Margin and Market Share (2021-2026)
  2.11.5 Shanghai Akcare Medical Technology Co., Ltd. Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Digital Therapeutics for Smoking Cessation Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
  3.2.1 Market Share of Digital Therapeutics for Smoking Cessation by Company Revenue
  3.2.2 Top 3 Digital Therapeutics for Smoking Cessation Players Market Share in 2025
  3.2.3 Top 6 Digital Therapeutics for Smoking Cessation Players Market Share in 2025
3.3 Digital Therapeutics for Smoking Cessation Market: Overall Company Footprint Analysis
  3.3.1 Digital Therapeutics for Smoking Cessation Market: Region Footprint
  3.3.2 Digital Therapeutics for Smoking Cessation Market: Company Product Type Footprint
  3.3.3 Digital Therapeutics for Smoking Cessation Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Digital Therapeutics for Smoking Cessation Consumption Value and Market Share by Type (2021-2026)
4.2 Global Digital Therapeutics for Smoking Cessation Market Forecast by Type (2027-2032)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Digital Therapeutics for Smoking Cessation Consumption Value Market Share by Application (2021-2026)
5.2 Global Digital Therapeutics for Smoking Cessation Market Forecast by Application (2027-2032)

6 NORTH AMERICA

6.1 North America Digital Therapeutics for Smoking Cessation Consumption Value by Type (2021-2032)
6.2 North America Digital Therapeutics for Smoking Cessation Market Size by Application (2021-2032)
6.3 North America Digital Therapeutics for Smoking Cessation Market Size by Country
  6.3.1 North America Digital Therapeutics for Smoking Cessation Consumption Value by Country (2021-2032)
  6.3.2 United States Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
  6.3.3 Canada Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
  6.3.4 Mexico Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)

7 EUROPE

7.1 Europe Digital Therapeutics for Smoking Cessation Consumption Value by Type (2021-2032)
7.2 Europe Digital Therapeutics for Smoking Cessation Consumption Value by Application (2021-2032)
7.3 Europe Digital Therapeutics for Smoking Cessation Market Size by Country
  7.3.1 Europe Digital Therapeutics for Smoking Cessation Consumption Value by Country (2021-2032)
  7.3.2 Germany Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
  7.3.3 France Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
  7.3.4 United Kingdom Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
  7.3.5 Russia Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
  7.3.6 Italy Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)

8 ASIA-PACIFIC

8.1 Asia-Pacific Digital Therapeutics for Smoking Cessation Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Digital Therapeutics for Smoking Cessation Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Digital Therapeutics for Smoking Cessation Market Size by Region
  8.3.1 Asia-Pacific Digital Therapeutics for Smoking Cessation Consumption Value by Region (2021-2032)
  8.3.2 China Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
  8.3.3 Japan Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
  8.3.4 South Korea Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
  8.3.5 India Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
  8.3.6 Southeast Asia Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
  8.3.7 Australia Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)

9 SOUTH AMERICA

9.1 South America Digital Therapeutics for Smoking Cessation Consumption Value by Type (2021-2032)
9.2 South America Digital Therapeutics for Smoking Cessation Consumption Value by Application (2021-2032)
9.3 South America Digital Therapeutics for Smoking Cessation Market Size by Country
  9.3.1 South America Digital Therapeutics for Smoking Cessation Consumption Value by Country (2021-2032)
  9.3.2 Brazil Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
  9.3.3 Argentina Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Digital Therapeutics for Smoking Cessation Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Digital Therapeutics for Smoking Cessation Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Digital Therapeutics for Smoking Cessation Market Size by Country
  10.3.1 Middle East & Africa Digital Therapeutics for Smoking Cessation Consumption Value by Country (2021-2032)
  10.3.2 Turkey Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
  10.3.3 Saudi Arabia Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)
  10.3.4 UAE Digital Therapeutics for Smoking Cessation Market Size and Forecast (2021-2032)

11 MARKET DYNAMICS

11.1 Digital Therapeutics for Smoking Cessation Market Drivers
11.2 Digital Therapeutics for Smoking Cessation Market Restraints
11.3 Digital Therapeutics for Smoking Cessation Trends Analysis
11.4 Porters Five Forces Analysis
  11.4.1 Threat of New Entrants
  11.4.2 Bargaining Power of Suppliers
  11.4.3 Bargaining Power of Buyers
  11.4.4 Threat of Substitutes
  11.4.5 Competitive Rivalry

12 INDUSTRY CHAIN ANALYSIS

12.1 Digital Therapeutics for Smoking Cessation Industry Chain
12.2 Digital Therapeutics for Smoking Cessation Upstream Analysis
12.3 Digital Therapeutics for Smoking Cessation Midstream Analysis
12.4 Digital Therapeutics for Smoking Cessation Downstream Analysis

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES

Table 1. Global Digital Therapeutics for Smoking Cessation Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Digital Therapeutics for Smoking Cessation Consumption Value by Business Models, (USD Million), 2021 & 2025 & 2032
Table 3. Global Digital Therapeutics for Smoking Cessation Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Global Digital Therapeutics for Smoking Cessation Consumption Value by Region (2021-2026) & (USD Million)
Table 5. Global Digital Therapeutics for Smoking Cessation Consumption Value by Region (2027-2032) & (USD Million)
Table 6. Click Therapeutics Company Information, Head Office, and Major Competitors
Table 7. Click Therapeutics Major Business
Table 8. Click Therapeutics Digital Therapeutics for Smoking Cessation Product and Solutions
Table 9. Click Therapeutics Digital Therapeutics for Smoking Cessation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 10. Click Therapeutics Recent Developments and Future Plans
Table 11. CureApp Company Information, Head Office, and Major Competitors
Table 12. CureApp Major Business
Table 13. CureApp Digital Therapeutics for Smoking Cessation Product and Solutions
Table 14. CureApp Digital Therapeutics for Smoking Cessation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 15. CureApp Recent Developments and Future Plans
Table 16. Pelago(Quit Genius) Company Information, Head Office, and Major Competitors
Table 17. Pelago(Quit Genius) Major Business
Table 18. Pelago(Quit Genius) Digital Therapeutics for Smoking Cessation Product and Solutions
Table 19. Pelago(Quit Genius) Digital Therapeutics for Smoking Cessation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 20. Ditch Labs Company Information, Head Office, and Major Competitors
Table 21. Ditch Labs Major Business
Table 22. Ditch Labs Digital Therapeutics for Smoking Cessation Product and Solutions
Table 23. Ditch Labs Digital Therapeutics for Smoking Cessation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Ditch Labs Recent Developments and Future Plans
Table 25. MindCotine Company Information, Head Office, and Major Competitors
Table 26. MindCotine Major Business
Table 27. MindCotine Digital Therapeutics for Smoking Cessation Product and Solutions
Table 28. MindCotine Digital Therapeutics for Smoking Cessation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. MindCotine Recent Developments and Future Plans
Table 30. Kwit Company Information, Head Office, and Major Competitors
Table 31. Kwit Major Business
Table 32. Kwit Digital Therapeutics for Smoking Cessation Product and Solutions
Table 33. Kwit Digital Therapeutics for Smoking Cessation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Kwit Recent Developments and Future Plans
Table 35. Pivot Health Company Information, Head Office, and Major Competitors
Table 36. Pivot Health Major Business
Table 37. Pivot Health Digital Therapeutics for Smoking Cessation Product and Solutions
Table 38. Pivot Health Digital Therapeutics for Smoking Cessation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Pivot Health Recent Developments and Future Plans
Table 40. Carrot Inc. Company Information, Head Office, and Major Competitors
Table 41. Carrot Inc. Major Business
Table 42. Carrot Inc. Digital Therapeutics for Smoking Cessation Product and Solutions
Table 43. Carrot Inc. Digital Therapeutics for Smoking Cessation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Carrot Inc. Recent Developments and Future Plans
Table 45. Beijing Wenzhi Technology Co., Ltd. Company Information, Head Office, and Major Competitors
Table 46. Beijing Wenzhi Technology Co., Ltd. Major Business
Table 47. Beijing Wenzhi Technology Co., Ltd. Digital Therapeutics for Smoking Cessation Product and Solutions
Table 48. Beijing Wenzhi Technology Co., Ltd. Digital Therapeutics for Smoking Cessation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Beijing Wenzhi Technology Co., Ltd. Recent Developments and Future Plans
Table 50. Hangzhou Yisu Technology Co., Ltd. Company Information, Head Office, and Major Competitors
Table 51. Hangzhou Yisu Technology Co., Ltd. Major Business
Table 52. Hangzhou Yisu Technology Co., Ltd. Digital Therapeutics for Smoking Cessation Product and Solutions
Table 53. Hangzhou Yisu Technology Co., Ltd. Digital Therapeutics for Smoking Cessation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Hangzhou Yisu Technology Co., Ltd. Recent Developments and Future Plans
Table 55. Shanghai Akcare Medical Technology Co., Ltd. Company Information, Head Office, and Major Competitors
Table 56. Shanghai Akcare Medical Technology Co., Ltd. Major Business
Table 57. Shanghai Akcare Medical Technology Co., Ltd. Digital Therapeutics for Smoking Cessation Product and Solutions
Table 58. Shanghai Akcare Medical Technology Co., Ltd. Digital Therapeutics for Smoking Cessation Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Shanghai Akcare Medical Technology Co., Ltd. Recent Developments and Future Plans
Table 60. Global Digital Therapeutics for Smoking Cessation Revenue (USD Million) by Players (2021-2026)
Table 61. Global Digital Therapeutics for Smoking Cessation Revenue Share by Players (2021-2026)
Table 62. Breakdown of Digital Therapeutics for Smoking Cessation by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Digital Therapeutics for Smoking Cessation, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 64. Head Office of Key Digital Therapeutics for Smoking Cessation Players
Table 65. Digital Therapeutics for Smoking Cessation Market: Company Product Type Footprint
Table 66. Digital Therapeutics for Smoking Cessation Market: Company Product Application Footprint
Table 67. Digital Therapeutics for Smoking Cessation New Market Entrants and Barriers to Market Entry
Table 68. Digital Therapeutics for Smoking Cessation Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Digital Therapeutics for Smoking Cessation Consumption Value (USD Million) by Type (2021-2026)
Table 70. Global Digital Therapeutics for Smoking Cessation Consumption Value Share by Type (2021-2026)
Table 71. Global Digital Therapeutics for Smoking Cessation Consumption Value Forecast by Type (2027-2032)
Table 72. Global Digital Therapeutics for Smoking Cessation Consumption Value by Application (2021-2026)
Table 73. Global Digital Therapeutics for Smoking Cessation Consumption Value Forecast by Application (2027-2032)
Table 74. North America Digital Therapeutics for Smoking Cessation Consumption Value by Type (2021-2026) & (USD Million)
Table 75. North America Digital Therapeutics for Smoking Cessation Consumption Value by Type (2027-2032) & (USD Million)
Table 76. North America Digital Therapeutics for Smoking Cessation Consumption Value by Application (2021-2026) & (USD Million)
Table 77. North America Digital Therapeutics for Smoking Cessation Consumption Value by Application (2027-2032) & (USD Million)
Table 78. North America Digital Therapeutics for Smoking Cessation Consumption Value by Country (2021-2026) & (USD Million)
Table 79. North America Digital Therapeutics for Smoking Cessation Consumption Value by Country (2027-2032) & (USD Million)
Table 80. Europe Digital Therapeutics for Smoking Cessation Consumption Value by Type (2021-2026) & (USD Million)
Table 81. Europe Digital Therapeutics for Smoking Cessation Consumption Value by Type (2027-2032) & (USD Million)
Table 82. Europe Digital Therapeutics for Smoking Cessation Consumption Value by Application (2021-2026) & (USD Million)
Table 83. Europe Digital Therapeutics for Smoking Cessation Consumption Value by Application (2027-2032) & (USD Million)
Table 84. Europe Digital Therapeutics for Smoking Cessation Consumption Value by Country (2021-2026) & (USD Million)
Table 85. Europe Digital Therapeutics for Smoking Cessation Consumption Value by Country (2027-2032) & (USD Million)
Table 86. Asia-Pacific Digital Therapeutics for Smoking Cessation Consumption Value by Type (2021-2026) & (USD Million)
Table 87. Asia-Pacific Digital Therapeutics for Smoking Cessation Consumption Value by Type (2027-2032) & (USD Million)
Table 88. Asia-Pacific Digital Therapeutics for Smoking Cessation Consumption Value by Application (2021-2026) & (USD Million)
Table 89. Asia-Pacific Digital Therapeutics for Smoking Cessation Consumption Value by Application (2027-2032) & (USD Million)
Table 90. Asia-Pacific Digital Therapeutics for Smoking Cessation Consumption Value by Region (2021-2026) & (USD Million)
Table 91. Asia-Pacific Digital Therapeutics for Smoking Cessation Consumption Value by Region (2027-2032) & (USD Million)
Table 92. South America Digital Therapeutics for Smoking Cessation Consumption Value by Type (2021-2026) & (USD Million)
Table 93. South America Digital Therapeutics for Smoking Cessation Consumption Value by Type (2027-2032) & (USD Million)
Table 94. South America Digital Therapeutics for Smoking Cessation Consumption Value by Application (2021-2026) & (USD Million)
Table 95. South America Digital Therapeutics for Smoking Cessation Consumption Value by Application (2027-2032) & (USD Million)
Table 96. South America Digital Therapeutics for Smoking Cessation Consumption Value by Country (2021-2026) & (USD Million)
Table 97. South America Digital Therapeutics for Smoking Cessation Consumption Value by Country (2027-2032) & (USD Million)
Table 98. Middle East & Africa Digital Therapeutics for Smoking Cessation Consumption Value by Type (2021-2026) & (USD Million)
Table 99. Middle East & Africa Digital Therapeutics for Smoking Cessation Consumption Value by Type (2027-2032) & (USD Million)
Table 100. Middle East & Africa Digital Therapeutics for Smoking Cessation Consumption Value by Application (2021-2026) & (USD Million)
Table 101. Middle East & Africa Digital Therapeutics for Smoking Cessation Consumption Value by Application (2027-2032) & (USD Million)
Table 102. Middle East & Africa Digital Therapeutics for Smoking Cessation Consumption Value by Country (2021-2026) & (USD Million)
Table 103. Middle East & Africa Digital Therapeutics for Smoking Cessation Consumption Value by Country (2027-2032) & (USD Million)
Table 104. Global Key Players of Digital Therapeutics for Smoking Cessation Upstream (Raw Materials)
Table 105. Global Digital Therapeutics for Smoking Cessation Typical Customers

LIST OF FIGURES

Figure 1. Digital Therapeutics for Smoking Cessation Picture
Figure 2. Global Digital Therapeutics for Smoking Cessation Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Digital Therapeutics for Smoking Cessation Consumption Value Market Share by Type in 2025
Figure 4. Cognitive Behavioral Therapy (CBT)-based
Figure 5. AI-driven Personalized Intervention
Figure 6. Digital Behavioral Feedback
Figure 7. Virtual Reality (VR)-assisted
Figure 8. Global Digital Therapeutics for Smoking Cessation Consumption Value by Business Models, (USD Million), 2021 & 2025 & 2032
Figure 9. Global Digital Therapeutics for Smoking Cessation Consumption Value Market Share by Business Models in 2025
Figure 10. B2C
Figure 11. B2B
Figure 12. B2B2C
Figure 13. Global Digital Therapeutics for Smoking Cessation Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 14. Digital Therapeutics for Smoking Cessation Consumption Value Market Share by Application in 2025
Figure 15. Digital Smoking Cessation Therapy for Adults Picture
Figure 16. Digital Smoking Cessation Therapy for Adolescents Picture
Figure 17. Digital Smoking Cessation Therapy for Special Populations Picture
Figure 18. Global Digital Therapeutics for Smoking Cessation Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 19. Global Digital Therapeutics for Smoking Cessation Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 20. Global Market Digital Therapeutics for Smoking Cessation Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 21. Global Digital Therapeutics for Smoking Cessation Consumption Value Market Share by Region (2021-2032)
Figure 22. Global Digital Therapeutics for Smoking Cessation Consumption Value Market Share by Region in 2025
Figure 23. North America Digital Therapeutics for Smoking Cessation Consumption Value (2021-2032) & (USD Million)
Figure 24. Europe Digital Therapeutics for Smoking Cessation Consumption Value (2021-2032) & (USD Million)
Figure 25. Asia-Pacific Digital Therapeutics for Smoking Cessation Consumption Value (2021-2032) & (USD Million)
Figure 26. South America Digital Therapeutics for Smoking Cessation Consumption Value (2021-2032) & (USD Million)
Figure 27. Middle East & Africa Digital Therapeutics for Smoking Cessation Consumption Value (2021-2032) & (USD Million)
Figure 28. Company Three Recent Developments and Future Plans
Figure 29. Global Digital Therapeutics for Smoking Cessation Revenue Share by Players in 2025
Figure 30. Digital Therapeutics for Smoking Cessation Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 31. Market Share of Digital Therapeutics for Smoking Cessation by Player Revenue in 2025
Figure 32. Top 3 Digital Therapeutics for Smoking Cessation Players Market Share in 2025
Figure 33. Top 6 Digital Therapeutics for Smoking Cessation Players Market Share in 2025
Figure 34. Global Digital Therapeutics for Smoking Cessation Consumption Value Share by Type (2021-2026)
Figure 35. Global Digital Therapeutics for Smoking Cessation Market Share Forecast by Type (2027-2032)
Figure 36. Global Digital Therapeutics for Smoking Cessation Consumption Value Share by Application (2021-2026)
Figure 37. Global Digital Therapeutics for Smoking Cessation Market Share Forecast by Application (2027-2032)
Figure 38. North America Digital Therapeutics for Smoking Cessation Consumption Value Market Share by Type (2021-2032)
Figure 39. North America Digital Therapeutics for Smoking Cessation Consumption Value Market Share by Application (2021-2032)
Figure 40. North America Digital Therapeutics for Smoking Cessation Consumption Value Market Share by Country (2021-2032)
Figure 41. United States Digital Therapeutics for Smoking Cessation Consumption Value (2021-2032) & (USD Million)
Figure 42. Canada Digital Therapeutics for Smoking Cessation Consumption Value (2021-2032) & (USD Million)
Figure 43. Mexico Digital Therapeutics for Smoking Cessation Consumption Value (2021-2032) & (USD Million)
Figure 44. Europe Digital Therapeutics for Smoking Cessation Consumption Value Market Share by Type (2021-2032)
Figure 45. Europe Digital Therapeutics for Smoking Cessation Consumption Value Market Share by Application (2021-2032)
Figure 46. Europe Digital Therapeutics for Smoking Cessation Consumption Value Market Share by Country (2021-2032)
Figure 47. Germany Digital Therapeutics for Smoking Cessation Consumption Value (2021-2032) & (USD Million)
Figure 48. France Digital Therapeutics for Smoking Cessation Consumption Value (2021-2032) & (USD Million)
Figure 49. United Kingdom Digital Therapeutics for Smoking Cessation Consumption Value (2021-2032) & (USD Million)
Figure 50. Russia Digital Therapeutics for Smoking Cessation Consumption Value (2021-2032) & (USD Million)
Figure 51. Italy Digital Therapeutics for Smoking Cessation Consumption Value (2021-2032) & (USD Million)
Figure 52. Asia-Pacific Digital Therapeutics for Smoking Cessation Consumption Value Market Share by Type (2021-2032)
Figure 53. Asia-Pacific Digital Therapeutics for Smoking Cessation Consumption Value Market Share by Application (2021-2032)
Figure 54. Asia-Pacific Digital Therapeutics for Smoking Cessation Consumption Value Market Share by Region (2021-2032)
Figure 55. China Digital Therapeutics for Smoking Cessation Consumption Value (2021-2032) & (USD Million)
Figure 56. Japan Digital Therapeutics for Smoking Cessation Consumption Value (2021-2032) & (USD Million)
Figure 57. South Korea Digital Therapeutics for Smoking Cessation Consumption Value (2021-2032) & (USD Million)
Figure 58. India Digital Therapeutics for Smoking Cessation Consumption Value (2021-2032) & (USD Million)
Figure 59. Southeast Asia Digital Therapeutics for Smoking Cessation Consumption Value (2021-2032) & (USD Million)
Figure 60. Australia Digital Therapeutics for Smoking Cessation Consumption Value (2021-2032) & (USD Million)
Figure 61. South America Digital Therapeutics for Smoking Cessation Consumption Value Market Share by Type (2021-2032)
Figure 62. South America Digital Therapeutics for Smoking Cessation Consumption Value Market Share by Application (2021-2032)
Figure 63. South America Digital Therapeutics for Smoking Cessation Consumption Value Market Share by Country (2021-2032)
Figure 64. Brazil Digital Therapeutics for Smoking Cessation Consumption Value (2021-2032) & (USD Million)
Figure 65. Argentina Digital Therapeutics for Smoking Cessation Consumption Value (2021-2032) & (USD Million)
Figure 66. Middle East & Africa Digital Therapeutics for Smoking Cessation Consumption Value Market Share by Type (2021-2032)
Figure 67. Middle East & Africa Digital Therapeutics for Smoking Cessation Consumption Value Market Share by Application (2021-2032)
Figure 68. Middle East & Africa Digital Therapeutics for Smoking Cessation Consumption Value Market Share by Country (2021-2032)
Figure 69. Turkey Digital Therapeutics for Smoking Cessation Consumption Value (2021-2032) & (USD Million)
Figure 70. Saudi Arabia Digital Therapeutics for Smoking Cessation Consumption Value (2021-2032) & (USD Million)
Figure 71. UAE Digital Therapeutics for Smoking Cessation Consumption Value (2021-2032) & (USD Million)
Figure 72. Digital Therapeutics for Smoking Cessation Market Drivers
Figure 73. Digital Therapeutics for Smoking Cessation Market Restraints
Figure 74. Digital Therapeutics for Smoking Cessation Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Digital Therapeutics for Smoking Cessation Industrial Chain
Figure 77. Methodology
Figure 78. Research Process and Data Source